Home » Newsletters » BioWorld

BioWorld

Oct. 20, 1992

View Archived Issues

ANOTHER PROBE ABSOLVES MEDAREX

APPOINTMENTS AND ADVANCEMENTS

UNIVAX PRESENTS EARLY RESULTS

BIOTECH STOCKS CONTINUE TO RISE

IMMUNEX OPENS NEW FACILITY

DNAP CONTROLS TOMATO RIPENING

AMPLIGEN OK'D FOR FATIGUE SYNDROME TRIALS

BBL'S AIDS VACCINE TRIALS APPROVED IN U.S.

ALAMAR TO COLLABORATE WITH ROERIG

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.